Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Peritoneal Neoplasms 1 Intestinal Fistula 1 Hernia, Ventral 1 Hernia 1 Fibromatosis, Abdominal 1 Desmoid Tumors 1

Interventions

Oxaliplatin 49 Fluorouracil 45 Leucovorin 42 Capecitabine 40 Irinotecan 31 Bevacizumab 31 Radiotherapy 24 Cetuximab 23 Radiation 13 Panitumumab 13 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 8 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 6 aflibercept 5 Immunohistochemistry 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 Fluorodeoxyglucose F18 4 Floxuridine 4 Celecoxib 4 trifluridine tipiracil drug combination 3 dehydroftorafur 3 XELOX 3 Sorafenib 3 Ramucirumab 3 Neoadjuvant Therapy 3 Erlotinib Hydrochloride 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × strattice × Clear all

NCT01927497 2021-08-17

BIOPEX

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 3 Completed

104 enrolled 8 charts

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡